Acurx Pharmaceuticals, Inc. SEC filings ACXP
Acurx Pharmaceuticals, Inc. has 245 filings in SEC EDGAR's recent list, going back to Apr 3, 2018. Its latest annual report, Form ARS, was filed on Sep 1, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 29, 2026 (bylaw or fiscal year change). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 4 | Insider transaction | Apr 22, 2026 | Apr 20, 2026 |
| 4 | Insider transaction | Apr 22, 2026 | Apr 20, 2026 |
| 4 | Insider transaction | Apr 22, 2026 | Apr 20, 2026 |
| 4 | Insider transaction | Apr 22, 2026 | Apr 20, 2026 |
| 4 | Insider transaction | Apr 22, 2026 | Apr 20, 2026 |
| 4 | Insider transaction | Apr 22, 2026 | Apr 20, 2026 |
| 4 | Insider transaction | Apr 22, 2026 | Apr 20, 2026 |
| 4 | Insider transaction | Apr 22, 2026 | Apr 20, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 14, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Aug 14, 2025 | — |
| 4 | Insider transaction | Feb 6, 2025 | Feb 5, 2025 |
| 4 | Insider transaction | Feb 6, 2025 | Feb 5, 2025 |
| 4 | Insider transaction | Feb 6, 2025 | Feb 5, 2025 |
| 4 | Insider transaction | Jan 8, 2025 | Jan 6, 2025 |
| 4 | Insider transaction | Jan 8, 2025 | Jan 6, 2025 |
| 4 | Insider transaction | Jan 8, 2025 | Jan 6, 2025 |
| 4 | Insider transaction | Jan 8, 2025 | Jan 6, 2025 |
| 4 | Insider transaction | Jan 8, 2025 | Jan 6, 2025 |
| 4 | Insider transaction | Jan 8, 2025 | Jan 6, 2025 |
| 4 | Insider transaction | Jun 18, 2024 | Jun 17, 2024 |
| 4 | Insider transaction | Jun 18, 2024 | Jun 17, 2024 |
| 4 | Insider transaction | Jun 18, 2024 | Jun 17, 2024 |
| 4 | Insider transaction | Jun 18, 2024 | Jun 17, 2024 |
| 4 | Insider transaction | Jun 18, 2024 | Jun 17, 2024 |
| 4 | Insider transaction | Apr 3, 2024 | Feb 23, 2024 |
| 4 | Insider transaction | Apr 3, 2024 | Feb 23, 2024 |
| 4 | Insider transaction | Apr 3, 2024 | Feb 23, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2024 | — |
| 4 | Insider transaction | Jan 22, 2024 | Jan 19, 2024 |
| 4 | Insider transaction | Jan 4, 2024 | Dec 2, 2021 |
| 4 | Insider transaction | Jan 4, 2024 | Jan 3, 2024 |
| 4 | Insider transaction | Jun 16, 2023 | Jun 15, 2023 |
| 4 | Insider transaction | Jun 16, 2023 | Jun 15, 2023 |
| 4 | Insider transaction | Jun 16, 2023 | Jun 15, 2023 |
| 4 | Insider transaction | Jun 16, 2023 | Jun 15, 2023 |
| 4 | Insider transaction | Jun 16, 2023 | Jun 15, 2023 |
| 4 | Insider transaction | Feb 24, 2023 | Feb 13, 2023 |
| 4 | Insider transaction | Feb 24, 2023 | Feb 13, 2023 |
| 4 | Insider transaction | Feb 24, 2023 | Feb 13, 2023 |
| SC 13G | Ownership over 5% (passive) | Feb 14, 2023 | — |
| SC 13G | Ownership over 5% (passive) | Feb 14, 2023 | — |
| 4 | Insider transaction | Jul 29, 2022 | Jul 27, 2022 |
| 4 | Insider transaction | Jul 29, 2022 | Jul 27, 2022 |
| 4 | Insider transaction | Jul 29, 2022 | Jul 27, 2022 |
| 4 | Insider transaction | Nov 24, 2021 | Nov 23, 2021 |
| 4 | Insider transaction | Nov 22, 2021 | Nov 19, 2021 |
| 4 | Insider transaction | Nov 22, 2021 | Nov 19, 2021 |
| 4 | Insider transaction | Sep 10, 2021 | Jun 29, 2021 |
| SC 13D | Ownership over 5% (active) | Jul 6, 2021 | — |
| SC 13D | Ownership over 5% (active) | Jul 6, 2021 | — |
| 4 | Insider transaction | Jul 6, 2021 | Jul 1, 2021 |
| 4 | Insider transaction | Jul 6, 2021 | Jul 1, 2021 |
| 4 | Insider transaction | Jul 6, 2021 | Jul 1, 2021 |
| 4 | Insider transaction | Jul 6, 2021 | Jul 1, 2021 |
| 4 | Insider transaction | Jul 6, 2021 | Jul 1, 2021 |
| 4 | Insider transaction | Jul 6, 2021 | Jun 29, 2021 |
| 4 | Insider transaction | Jul 6, 2021 | Jun 29, 2021 |
| 4 | Insider transaction | Jul 6, 2021 | Jun 29, 2021 |
| 3 | Initial insider ownership | Jun 24, 2021 | Jun 24, 2021 |
| 3 | Initial insider ownership | Jun 24, 2021 | Jun 24, 2021 |
| 3 | Initial insider ownership | Jun 24, 2021 | Jun 24, 2021 |
| 3 | Initial insider ownership | Jun 24, 2021 | Jun 24, 2021 |
| 3 | Initial insider ownership | Jun 24, 2021 | Jun 24, 2021 |
| 3 | Initial insider ownership | Jun 24, 2021 | Jun 24, 2021 |
| 3 | Initial insider ownership | Jun 24, 2021 | Jun 24, 2021 |
| 3 | Initial insider ownership | Jun 24, 2021 | Jun 24, 2021 |
Showing 66 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ACXP (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Staten Island, NY
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1736243
- Former names
- Acurx Pharmaceuticals, LLC (until Jun 23, 2021)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.